CRL
Charles River Laboratories International, Inc. · Healthcare
Insiders sold $52.1M of Charles River Laboratories International, Inc. in the last 12 months and bought none
CRL over the last year
CRL after insider buys
3 months after each buy, from the first price a copier could get.
3 buys since 2020 with 3 months of prices.
Congress
Members reported 24 trades in CRL since 2023.
Every filing
212 insider filings since 2016, newest first
James C Foster · Director
Shannon M Parisotto · CEVP, Disc & Safety Assessment
Shannon M Parisotto · CEVP, Disc & Safety Assessment
James C Foster · Director
Shannon M Parisotto · CEVP, Disc & Safety Assessment
Nancy C Andrews · Director
Birgit Girshick · Chief Executive Officer
Shannon M Parisotto · CEVP, Disc & Safety Assessment
James C Foster · Director
Michael Gunnar Knell · SVP, Finance and CAO
Victoria L Creamer · EVP and Chief People Officer
Shannon M Parisotto · CEVP, Disc & Safety Assessment
James C Foster · Director
Joseph W Laplume · EVP, Corp Strategy, Develop
James C Foster · Chair, President and CEO
Birgit Girshick · Corporate EVP, COO
Richard F Wallman · Director
Joseph W Laplume · EVP, Corp Strategy, Develop
James C Foster · Chair, President and CEO
Michael Gunnar Knell · CSVP, Chief Accounting Officer
George Massaro · Director
Joseph W Laplume · EVP, Corp Strategy, Develop
Michael Gunnar Knell · CSVP, Chief Accounting Officer
Shannon M Parisotto · CEVP, Disc, Safety Assessment
Victoria L Creamer · EVP and Chief People Officer
William D Barbo · Corporate EVP, CCO
Shannon M Parisotto · CEVP, Disc, Safety Assessment
Joseph W Laplume · EVP, Corp Strategy, Develop
Victoria L Creamer · EVP and Chief People Officer
Joseph W Laplume · EVP, Corp Strategy, Develop
Joseph W Laplume · EVP, Corp Strategy, Develop
William D Barbo · Corporate EVP, CCO
Michael Gunnar Knell · CSVP, Chief Accounting Officer
Joseph W Laplume · EVP, Corp Strategy, Develop
Joseph W Laplume · EVP, Corp Strategy, Develop
Joseph W Laplume · EVP, Corp Strategy, Develop
George Massaro · Director
Richard F Wallman · Director
Shannon M Parisotto · CEVP, Disc, Safety Assessment
Birgit Girshick · Corporate EVP, COO
James C Foster · Chair, President and CEO
Richard F Wallman · Director
William D Barbo · Corporate EVP, CCO
Joseph W Laplume · EVP, Corp Strategy, Develop
Michael Gunnar Knell · CSVP, Chief Accounting Officer
Shannon M Parisotto · CEVP, Disc, Safety Assessment
Joseph W Laplume · EVP, Corp Strategy, Develop
Joseph W Laplume · EVP, Corp Strategy, Develop
George Massaro · Director
David Ross Smith · Corporate EVP, CFO
About Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.